Paradigms for Treating Breast Cancers Have Changed: The One-Size-Fits-All Is no Longer True

Main Article Content

Remy Salmon


Breast cancer, Treatment, New paradigm in Breast Cancer management




1. Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321(3):288-300.
2. Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life. 2015;8(2):176-80.
3. Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303-10.
4. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918-26.
5. Sanz J, Zhao M, Rodriguez N, Granado R, Foro P, et al. Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients. Biomed Res Int. 2018;2018:8321871.
6. Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, et al. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells. 2019;8(10).

Article Statistics :Views : 469 | Downloads : 547